For men considering
radiation after radical
prostatectomy

Genomic Profiling for Prostate Cancer

Based on tumor biology alone, Decipher offers superior accuracy in predicting risk of progression, enabling the patient and physician to optimize clinical decisions.

highest-reported-accuracy

Highest Reported Accuracy

independent of risk factors such as PSA, stage and Gleason score

comprehensive-geo

Comprehensive Genomics

unmatched by any other option available to physicians in the United States today

standard-of-care

Standard of Care Testing

covered by Medicare and recommended by clinical practice guidelines

Indicated for:

Men considering early or salvage radiation after radical prostatectomy

Predictive of:

Metastasis
-
Prostate cancer mortality

Recommended by:

NCCN Clinical Practice Guidelines for prostate cancer

Clinically validated in multiple published studies of more than
1,900 unique patients

Publications

Dr. Robert Den

Thomas Jefferson University, PA

“After prostatectomy, many men are unsure of what further treatment, if any is beneficial for them. This can cause much anxiety and concern. Decipher RP assists doctors and patients in making more informed decisions about the next steps along the cancer journey.”

Physicians \ Order a Test

Order Online:
New users:

Sign up for a new account by contacting Customer Support at:

888.792.1601 or:

cs@decipherbio.com

Current Users:
Or Order
by Fax:

1. Download and complete the appropriate Test Requisition Form below:

2. Fax the completed form, along with the pathology report and insurance information to:

858.408.7420

Specimen Acceptance Criteria

Decipher
Prostate Biopsy

Gleason 3+3 = 6
(PSA < 20 ng/mL)

or:

Gleason 3+4 = 7
(all PSA values)

Decipher
Prostate RP

Surgical Margin Positive

or:

pT3a
(extraprostatic extension or
bladder neck invasion)

or:

pT3b
(seminal vesicle invasion)

or:

Biochemical Recurrence
(with 2 consecutive rises in PSA)

Decipher
Bladder

TURBT
(Trans-Urethral Resection
of Bladder Tumor)

and:

Urothelial/Transitional Cell Muscle Invasive Carcinoma

Patients \ Insurance Information

Decipher Biosciences is committed to ensuring access for all patients.
Decipher Prostate

Decipher Prostate is covered by Medicare, Medicare Advantage and select private insurers.

Through Decipher Assist, we offer programs designed to ensure testing is affordable for patients, including:

• Financial assistance for patients with demonstrated financial need

• Tailored payment plans to accommodate certain specific financial circumstances

For more information on the Decipher test and Decipher Assist, please contact the Decipher Assist team at:

888.792.1601 or download the Decipher Assist brochure.

Decipher Bladder

Decipher Bladder is available on a self-pay basis. For more information, please contact the Decipher team at:

888.792.1601

Decipher SM Icons

Please enter your name & email address below to download your PDF:

  • This field is for validation purposes and should be left unchanged.